Profile
Sector:
TechnologyIndustry:
Electronics & Computer DistributionCountry:
United StatesIPO:
03 May 1973Website:
http://www.avnet.comNext earnings report:
31 January 2025Last dividends:
11 September 2024Next dividends:
N/APrice
regular market | 1 min agoAnalysts recommendations
Institutional Ownership
Included in screeners
AVT Latest News
Examine Avnet's (AVT) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
REYKJAVIK, Iceland and LONDON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT05, Alvotech's proposed biosimilar to Simponi® (golimumab), a biologic used to treat several chronic inflammatory diseases. This is believed to be the first marketing authorization application filing announced globally for a biosimilar candidate to Simponi. The approvals process is anticipated to be completed in the fourth quarter of 2025.
While the top- and bottom-line numbers for Avnet (AVT) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT03, a proposed biosimilar candidate to Prolia® and Xgeva® (denosumab).
REYKJAVIK, Iceland, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT03, a proposed biosimilar candidate to Prolia® and Xgeva® (denosumab).
MELBOURNE, Australia--(BUSINESS WIRE)---- $AVT #Avnet--Avnet has been awarded the contract to supply Huizhong's SCL61H-100 smart ultrasonic water meters to South East Water (SEW).
24/7 Wall St. Insights Companies that raise their dividends regularly are outstanding ideas for investors.
PHOENIX--(BUSINESS WIRE)-- #Avnet--Avnet names Ginnie Henkels and Helmut Gassel to its Board of Directors.
REYKJAVIK, Iceland and LONDON, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT06, Alvotech's proposed biosimilar to Eylea® (aflibercept). The process to obtain marketing authorization could be completed in the third quarter of 2025.
Explore how Avnet's (AVT) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
What type of business is Avnet?
Avnet, Inc. is a distributor of electronic components. The company has been in operation since 1921 and was registered in New York in 1955. The electronic components group sells electronic components, including semiconductors, interconnects, passive and electromechanical components, as well as other integrated components from leading global electronic component manufacturers primarily for large customers. The Farnell group, on the other hand, supports customers with small sales volumes who need electronic components for rapid development, prototyping, and testing of their products. Farnell distributes a wide range of kits, tools, electronic components, industrial automation components, as well as products for testing and measurement.
What sector is Avnet in?
Avnet is in the Technology sector
What industry is Avnet in?
Avnet is in the Electronics & Computer Distribution industry
What country is Avnet from?
Avnet is headquartered in United States
When did Avnet go public?
Avnet initial public offering (IPO) was on 03 May 1973
What is Avnet website?
https://www.avnet.com
Is Avnet in the S&P 500?
No, Avnet is not included in the S&P 500 index
Is Avnet in the NASDAQ 100?
No, Avnet is not included in the NASDAQ 100 index
Is Avnet in the Dow Jones?
No, Avnet is not included in the Dow Jones index
When was Avnet the previous earnings report?
No data
When does Avnet earnings report?
The next expected earnings date for Avnet is 31 January 2025